-
2024-514652-33-00
4
Relapsed Multiple Myeloma
-
2024-519087-41-00
5
Breast cancer is the most common form of cancer among women in North A
-
2025-521037-86-00
5
Immune system diseases
-
2025-521038-27-00
5
Immune system diseases
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2025-521035-37-00
5
2026-03-02
Immune system diseases
-
2025-522451-25-00
4
2026-02-17
Large hernia width, chronically retracted lateral abdominal wall muscl
-
2025-521242-26-00
4
2025-11-27
Moderately to Severely Active Ulcerative Colitis
-
2024-519827-16-00
5
2025-09-30
Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients
-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2024-515934-34-00
6
2025-01-28
Low-cardiac output syndrome (LCOS)
-
2023-508741-40-00
10
2025-01-14
Non-small cell lung cancer
-
2024-517863-22-00
5
2024-12-01
Study population consists in patients with a diagnosis of mCRC who hav
-
2024-511018-18-00
5
2024-08-09
patients with aortic stenosis underwent transcatheter aortic valve rep
-
2023-503895-25-00
5
2024-08-01
criticall illness
-
2023-509551-14-00
5
2024-06-12
Unresectable left sided RAS/B-RAF wild-type metastatic colorectal canc
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2024-513621-23-00
5
2025-04-18
Advanced/metastatic non-small cell lung cancer (NSCLC)
-
2023-506668-15-00
5
2024-06-17
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2022-502446-27-00
5
2024-02-26
Relapsed or Refractory Myeloma
-
2024-518304-53-00
5
2022-02-02
Relapsed or Refractory Multiple Myeloma (RRMM)